Literature DB >> 2471803

Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses.

A Sanchez1, D Y Pifat, R H Kenyon, C J Peters, J B McCormick, M P Kiley.   

Abstract

Twenty-one monoclonal antibodies reactive with Junin virus structural proteins were produced and characterized. Using radioimmunoprecipitation and Western blot assays, 13 were found to react with the nucleoprotein, seven with the surface glycoprotein and one failed to react, but showed a fluorescent antibody staining pattern consistent with other glycoprotein-specific antibodies. In radioimmunoprecipitation assays, glycoprotein-specific monoclonal antibodies reacted not only with the 35K structural glycoprotein, but also with what is presumed to be the glycoprotein precursor. Four of seven glycoprotein-specific antibodies neutralized Junin virus to high titres. Cross-reactivity with other arenaviruses was found to be restricted to nucleoprotein-specific monoclonal antibodies and occurred only with New World arenaviruses. Cross-reactivity also shows the Junin virus to be most closely related to Machupo and Tacaribe viruses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471803     DOI: 10.1099/0022-1317-70-5-1125

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  74 in total

1.  Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion.

Authors:  Emily L Messina; Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

2.  Diversity and phylogenetic relationships among the North American Tacaribe serocomplex viruses (family Arenaviridae).

Authors:  Maria N B Cajimat; Mary Louise Milazzo; Michelle L Haynie; J Delton Hanson; Robert D Bradley; Charles F Fulhorst
Journal:  Virology       Date:  2011-10-08       Impact factor: 3.616

3.  An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion.

Authors:  Joanne York; Jody D Berry; Ute Ströher; Qunnu Li; Heinz Feldmann; Min Lu; Meg Trahey; Jack H Nunberg
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

4.  Role of the stable signal peptide of Junín arenavirus envelope glycoprotein in pH-dependent membrane fusion.

Authors:  Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell.

Authors:  Jillian M Rojek; Kevin P Campbell; Michael B A Oldstone; Stefan Kunz
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

6.  Genetic diversity among Bolivian arenaviruses.

Authors:  Maria N B Cajimat; Mary Louise Milazzo; Pierre E Rollin; Stuart T Nichol; Michael D Bowen; Thomas G Ksiazek; Charles F Fulhorst
Journal:  Virus Res       Date:  2008-12-19       Impact factor: 3.303

7.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

8.  Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.

Authors:  Yi-Ying Chou; Christian Cuevas; Margot Carocci; Sarah H Stubbs; Minghe Ma; David K Cureton; Luke Chao; Frances Evesson; Kangmin He; Priscilla L Yang; Sean P Whelan; Susan R Ross; Tom Kirchhausen; Raphaël Gaudin
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 9.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

10.  Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers.

Authors:  Ricardo Carrion; Peter Bredenbeek; Xiaohong Jiang; Irina Tretyakova; Peter Pushko; Igor S Lukashevich
Journal:  J Vaccines Vaccin       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.